Podcast
#53: Don’t Wait for the Wake-Up Call
Duration: 12 Minutes
Nov 19, 2025
Our 53rd episode of QuidelOrtho Science Bytes features Dr. Qian Ding, MD, PhD, exploring why early detection of diabetes is a clinical and economic imperative.
From identifying silent disease progression to leveraging smarter lab platforms, early testing empowers clinicians to intervene sooner, personalize care and help prevent costly complications.
Dr. Ding shares how diagnostics and emerging biomarkers are helping reshape diabetes care – delivering fast, reliable insights that support proactive treatment and healthier outcomes.
Downloads
Transcripts
Disclaimers:
This educational podcast activity is brought to you by QuidelOrtho Corporation., and is not certified for continuing medical education. QuidelOrtho Corporation sponsors the program, and the speaker must present information following applicable FDA requirements.
About our Speaker:
About our Speaker:
Dr. Qian Ding, MD, PhD
Senior Medical Affairs Manager
QuidelOrtho
Dr. Ding brings extensive experience in hospital laboratory and in vitro diagnostics with a strong command of healthcare information systems and data analytics. With a comprehensive background in microbiology, immunology, molecular genetics and healthcare business intelligence, Dr. Ding is also an accomplished researcher with an established record of publications in reputable peer-reviewed scientific journals. She's also recognized as a leader at the intersection of science, technology and healthcare.
Dr. Ding brings extensive experience in hospital laboratory and in vitro diagnostics with a strong command of healthcare information systems and data analytics. With a comprehensive background in microbiology, immunology, molecular genetics and healthcare business intelligence, Dr. Ding is also an accomplished researcher with an established record of publications in reputable peer-reviewed scientific journals. She's also recognized as a leader at the intersection of science, technology and healthcare.
Key Takeaways:
- Early action saves lives: Detect diabetes before complications occur
- Beyond glucose: Biomarkers like C-peptide and adiponectin reveal risk earlier
- Smarter labs, faster answers: Automation-ready platforms streamline workflows
- Economic impact: Early testing reduces long-term costs and supports value-based care
- Equity in care: Tailored strategies ensure accurate diagnosis across diverse populations
